Owner Scorecard


← All companies ← BHRB Manual BILL → ← BEAM Biotechnology BNTX →

BIIB, Biogen Inc.

Biotechnology consumer brand Cyclical

Biogen is a global biopharmaceutical company focused on discovering, developing and delivering innovative therapies for people living with serious and complex diseases.

We market the first and only drug approved in the U.S., the E.U. and certain international markets for the treatment of FA in adults and adolescents aged 16 years and older.

Our marketed products include VUMERITY, TYSABRI, TECFIDERA, AVONEX and PLEGRIDY for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of FA; and QALSODY for the treatment of ALS.

Latest annual: FY2025 10-K
BIIB · Biogen Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$9.9B
+2.2% YoY · −6% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $9.9B 5-yr avg $10.1B
Gross margin 75% 5-yr avg 77%
Operating margin 24.9% 5-yr avg 22.0%
ROIC 10% 5-yr avg 9%
Owner-earnings margin 24% 5-yr avg 21%
Free cash flow margin 24% 5-yr avg 21%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power.
What moves the needle
Gross margin has run about 81% and operating margin about 34% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. The operating margin has swung widely — from 13% to 49% — on a steadier 81% gross margin, so what moves it sits below the gross line, in operating spend and one-off charges more than in the cost of the product itself. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has run in the teens (median 18%, above 15% in 6 of 9 years). Owner earnings agree: roughly 29% of revenue reaches owners as cash, consistently. Returns like these are solid but short of clear franchise economics; whether they hold is what the 10-K settles, not the multiple.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$11.4B$12.3B$13.5B$14.4B$13.4B$11.0B$10.2B$9.8B$9.7B$9.9B$9.9BRevenueRevenue
87%87%86%86%87%81%78%74%76%76%75%Gross marginGross mgn
17%16%16%17%19%24%24%26%25%25%25%SG&A / revenueSG&A/rev
17%18%19%16%30%23%22%25%20%18%19%R&D / revenueR&D/rev
$5.2B$5.3B$5.9B$7.0B$4.6B$2.8B$3.6B$1.3B$1.9B$1.6B$2.5BOperating incomeOp. inc.
45.0%43.6%43.8%49.0%33.8%25.9%35.3%13.2%19.7%15.7%24.9%Operating marginOp. mgn
$3.7B$2.5B$4.4B$5.9B$4.0B$1.6B$3.0B$1.2B$1.6B$1.3B$1.4BNet incomeNet inc.
25%49%24%16%20%3%17%10%14%17%15%Effective tax rateTax rate
Cash flow & returns
$4.6B$4.6B$6.2B$7.1B$4.2B$3.6B$1.4B$1.5B$2.9B$2.2B$2.6BOperating cash flowOp. cash
$683M$1.1B$651M$465M$457M$488M$518M$495M$673M$780M$801MDepreciationDeprec.
$47M$803M$949M$543M($426M)$1.4B($2.4B)($373M)$279M($159M)$124MWorking capital & otherWC & other
$616M$867M$771M$515M$425M$258M$240M$277M$154M$154M$168MCapexCapex
5.4%7.1%5.7%3.6%3.2%2.4%2.4%2.8%1.6%1.6%1.7%Capex / revenueCapex/rev
$4.0B$3.7B$5.4B$6.6B$3.8B$3.4B$1.1B$1.3B$2.7B$2.1B$2.4BOwner earningsOwner earn.
34.7%30.0%40.3%45.7%28.3%30.8%11.2%12.9%28.1%20.7%24.4%Owner earnings marginOE mgn
$4.0B$3.7B$5.4B$6.6B$3.8B$3.4B$1.1B$1.3B$2.7B$2.1B$2.4BFree cash flowFCF
34.7%30.0%40.3%45.7%28.3%30.8%11.2%12.9%28.1%20.7%24.4%Free cash flow marginFCF mgn
$0$0$0$744M$6.9B$1.1B$0AcquisitionsAcquis.
$1.0B$1.4B$4.4B$5.9B$6.7B$1.8B$750M$0$0BuybacksBuybacks
24%16%25%36%22%18%6%7%6%10%ROICROIC
31%20%34%44%37%14%23%8%10%7%7%Return on equityROE
31%20%34%44%37%14%23%8%10%7%7%Retained to equityRetained/eq
Balance sheet
$7.7B$6.7B$4.9B$5.9B$1.3B$2.3B$3.4B$1.0B$2.4B$3.0B$6.4BCash & investmentsCash+inv
$1.4B$1.8B$2.0B$1.9B$1.9B$1.5B$1.7B$1.7B$1.4B$1.3B$1.3BReceivablesReceiv.
$1.0B$903M$930M$804M$1.1B$1.4B$1.3B$2.5B$2.5B$2.2B$1.9BInventoryInvent.
$280M$396M$371M$531M$455M$589M$492M$403M$424M$432M$359MAccounts payablePayables
$2.2B$2.3B$2.5B$2.2B$2.5B$2.3B$2.6B$3.8B$3.4B$3.1B$2.9BOperating working capitalOper. WC
$8.7B$7.9B$7.6B$8.4B$6.9B$7.9B$9.8B$6.9B$7.5B$9.0B$9.2BCurrent assetsCur. assets
$3.4B$3.4B$3.3B$4.9B$3.7B$4.3B$3.3B$3.4B$5.5B$3.3B$3.0BCurrent liabilitiesCur. liab.
2.6×2.3×2.3×1.7×1.8×1.8×3.0×2.0×1.3×2.7×3.1×Current ratioCurr. ratio
$3.7B$4.6B$5.7B$5.8B$5.8B$5.8B$5.7B$6.2B$6.5B$6.5B$6.5BGoodwillGoodwill
$22.9B$23.7B$25.3B$27.2B$24.6B$23.9B$24.6B$26.8B$28.0B$29.4B$29.5BTotal assetsAssets
$6.6B$6.0B$6.0B$6.0B$7.5B$7.6B$6.3B$7.1B$8.0B$6.3B$6.3BTotal debtDebt
($1.2B)($743M)$1.1B$116M$6.2B$5.3B$2.9B$6.0B$5.7B$3.3B($65M)Net debt / (cash)Net debt
19.8×21.3×29.4×37.6×20.4×11.2×14.6×5.3×7.6×5.8×9.0×Interest coverageInt. cov.
$12.1B$12.6B$13.0B$13.3B$10.7B$10.9B$13.4B$14.8B$16.7B$18.3B$18.7BShareholders’ equityEquity
1.4%1.0%1.2%1.3%1.5%2.2%2.5%2.7%3.0%2.9%3.0%Stock comp / revenueSBC/rev
Per share
219M213M205M187M161M150M146M146M146M147M148MShares out (diluted)Shares
$52.33$57.62$65.53$76.72$83.35$73.41$69.68$67.55$66.32$67.24$66.96Revenue / shareRev/sh
$16.92$11.92$21.58$31.42$24.80$10.40$20.87$7.97$11.19$8.79$9.24EPS (diluted)EPS
$18.15$17.29$26.39$35.03$23.59$22.61$7.84$8.72$18.66$13.94$16.33Owner earnings / shareOE/sh
$18.15$17.29$26.39$35.03$23.59$22.61$7.84$8.72$18.66$13.94$16.33Free cash flow / shareFCF/sh
$2.82$4.07$3.75$2.75$2.63$1.73$1.65$1.90$1.05$1.05$1.13Cap. spending / shareCapex/sh
$55.48$59.22$63.51$71.20$66.34$72.84$91.77$101.64$114.57$124.11$125.69Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+2.8%/yr−4.2%/yr
Owner earnings / share−2.9%/yr−10.0%/yr
EPS−7.0%/yr−18.7%/yr
Capital spending / share−10.4%/yr−16.9%/yr
Book value / share+9.4%/yr+13.3%/yr

The record, charted

FY2016–2025

Each measure over its full record; the current point and the worst year marked.

Share count
147Mpeak FY2016
ROIC
6%low FY2023
Gross margin
76%low FY2023

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$2.1Bowner earningsvs.$1.3Bnet incomelow FY2022

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $1.3B of profit into $2.1B of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$1.3B
Owner earnings$2.1B · 21% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$1.3B$1.6B$1.2B$3.0B$1.6B
Depreciation & amortizationnon-cash charge added back+$780M+$673M+$495M+$518M+$488M
Stock-based compensationreal costnon-cash, but a real cost+$291M+$291M+$264M+$254M+$239M
Working capital & othertiming of cash in and out, other non-cash items−$159M+$279M−$373M−$2.4B+$1.4B
Cash from operations$2.2B$2.9B$1.5B$1.4B$3.6B
Capital expenditurecash put back in to keep running and to grow−$154M−$154M−$277M−$240M−$258M
Owner earnings$2.1B$2.7B$1.3B$1.1B$3.4B
Owner-earnings marginowner earnings ÷ revenue21%28%13%11%31%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $291M), owner earnings is nearer $1.8B.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $2.8B ÷ interest expense $268M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • How heavy is the debt, net of cash? $1.7B · 0.6× operating profit
    Modest net debt
    Cash $3.0B + ST investments $1.6B − debt $6.3B
    What this means

    Netting $4.6B of cash and short-term investments against $6.3B of debt leaves $1.7B owed, about 0.6× a year's operating profit (2.2× on the gross debt, before the cash). It also holds $1.4B in longer-dated marketable securities; counting those, it sits at $308M of net debt. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 50 + DIO 329 − DPO 66 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • High through the cycle
    9-yr median, range 6%–36%; the latest year is left out — large non-operating charges put its operating line well above pretax profit
    Industry peers: median 17%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 9 years, so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High through the cycle
    10-yr median margin, range 11%–46%; latest $2.1B = operating cash $2.2B − maintenance capex $154M
    Industry peers: median 22%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 21% of revenue this year, a 28% median across 10 years. Treating stock comp as the real expense it is (less $291M of SBC) leaves $1.8B.

  • Cash-backed
    Cash from ops $2.2B ÷ net income $1.3B
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Reinvests most of it
    Dividends + buybacks $0 ÷ Owner Earnings $2.1B
    What this means

    Of $2.1B Owner Earnings, $0 (0%) went back to shareholders, $0 dividends, $0 buybacks. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.

  • Investing or harvesting? 0.20×
    Harvesting
    Capex $154M ÷ depreciation $780M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 3 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Pass
    Revenue ≥ $2B · $9.9B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 2.68×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Near
    Debt ≤ working capital · $6.3B vs $5.6B WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Pass
    A profit every year (10-yr record) · no losses
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · none paid
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth Miss
    Earnings +33% over the record · −62%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $9.23/share (latest year $8.76), the averaged base the calculator's gate runs on, and book value is $123.66/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 10 of 10
    What this means

    Never lost money over the record, the earnings stability Graham insisted on.

  • Return on capital ≥ 15% 7 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 44% → 16% (3-yr avg ends)

    In the filing’s words The filing attributes gains to higher prices but names price competition too — and the margin slipped, so the pressure is winning here.

    What this means

    Through the cycle the operating margin slipped — about 44% early to 16% lately, median 34% — competition or costs are biting in.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Owner earnings growth −5%/yr
    What this means

    Owner earnings shrank about 5% a year over the record.

  • Worst year 2023 · 13.2% op. margin
    What this means

    Stayed profitable even in its hardest year, the resilience that survives recessions.

  • Share count −4.3%/yr
    What this means

    The share count is shrinking, buybacks are quietly growing your slice of the business.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

In its own filing Framed as a capability

The filing positions AI as something the company uses, not something it fears.

“The increasing use of AI-based software presents new risks and challenges and could adversely affect our business and reputation.”

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat, and the company is using it that way.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$9.2B
  • Cash & short-term investments$4.9B
  • Receivables$1.3B
  • Inventory$1.9B
  • Other current assets$954M
Current liabilities$3.0B
  • Accounts payable$359M
  • Other current liabilities$2.6B
Current ratio3.06×all current assets ÷ what's due · Graham looked for 2×
Quick ratio2.41×stricter: inventory excluded
Cash ratio1.65×strictest: cash alone against what's due
Working capital$6.2Bthe cushion left after near-term bills
Revenue, latest quarter vs. a year ago+1.9%the freshest read on whether the business is still growing
Current ratio, recent quarters2.3× → 3.1×
Deeper floors
Tangible book value$3.1Bequity stripped of goodwill & intangibles
Net current asset value($1.6B)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$6.6B$354M of it operating leases
Deferred revenue$56Mcustomer cash collected before delivery; operating float

From the company's latest filing.

Not how much it owes, but when it falls due, and against what. The ladder the company files, beside cash on hand and a year's owner earnings.

'27$0
'28$0
'29$0
'30$1.5B

Bars scaled to the largest single year.

Due in the next 12 months$0the first rung: what must be repaid or rolled over within the year
Within two years$0the near wall, the part most exposed to today’s credit conditions
Biggest single year$1.5Bin 2030the lumpiest maturity, where a refinancing, if needed, is largest
Due over the next five years$1.5Bthe near slice; the balance sheet carries $6.3B of debt in all

Maturity schedule extracted from the company’s Dec 31, 2025 annual report and reconciled to the balance-sheet debt.

How the cash was used, 2016–2025

Over the record, the business generated $38.3B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$4.3B · 11%
  • Buybacks$21.8B · 57%
  • Retained (debt / cash)$12.2B · 32%
  • Returned to owners$21.8B

    64% of the owner earnings the business produced over the span, $0 as dividends and $21.8B as buybacks.

  • Average price paid for buybacks

    Buybacks ran $21.8B over the span, but a stock split in the window left the reported buyback-share counts on a basis the diluted-share count doesn't match, so a comparable average price can't be drawn.

  • Net change in share count−32.2%

    The diluted count fell from 219M to 148M, so the buybacks outran the stock issued to staff.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

  • Return on what it retained−32%

    Of the earnings it kept rather than paid out ($7.4B over the span), annual owner earnings (first three years vs last three) fell $2.3B, so each retained $1 gave back about 0.32 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$15.7B53% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity36%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$8.7Bover 10 years buying other businesses, against $4.3B of capital spent building

None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Mr. Vounatsos$17.7M$15.2M$3.4B
2022Mr. Viehbacher$30.5M$27.6M$1.1B
2022Mr. Vounatsos$26.6M$5.9M$1.1B
2023Mr. Viehbacher$4.1M−$4.5M$1.3B
2024Mr. Viehbacher$24.2M$1.3M$2.7B
2025Mr. Viehbacher$23.6M$27.7M$2.1B

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership<1%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • CEO pay ratio113:1

    What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.

  • Stock-based compensation$291M

    The slice of the business handed to employees in shares this year, 3% of revenue, equal to 10% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why Biogen Inc. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.

2 of the 6 tests turned up something to look into; the other 4 came back clean.

  • Look hereIs it less profitable than it was?20.6% vs 35.0%

    The owner-earnings margin averaged 35.0% early in the record and 20.6% across the last three years, and the latest year has not recovered. Ask the filing whether that is a structural drift or a cyclical trough — price, mix, cost, or a competitor — and whether it is permanent.

  • Look hereDid receivables and inventory outpace sales?21% → 33% of sales

    Receivables and inventory grew from $2.4B to $3.3B while revenue grew −13%: working capital is climbing faster than sales (21% of revenue then, 33% now). That can mean customers paying slower, stock building up, or revenue pulled forward. The filing's cash-flow and receivables notes say which.

And these came back clean
  • Did the share count rise anyway?
  • Did debt outgrow the business?
  • Did reported profit become cash?
  • Are "one-time" charges a yearly habit?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Income taxes, Inventory, Acquisitions as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Biotechnology

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
GILDGilead Sciences Inc.$29.4B79%31.0%15%35%
REGNRegeneron Pharmaceuticals Inc.$14.3B34.6%21%31%
VTRSViatris$14.3B34%2.5%0%14%
VRTXVertex Pharmaceuticals Incorporated$12.0B87%31.8%36%34%
BHCBausch Health Companies Inc.$10.3B76%5.5%2%13%
BIIBBiogen Inc.$9.9B84%34.6%18%29%
ZTSZoetis Inc.$9.5B69%34.2%26%22%
OGNOrganon$6.2B62%25.0%17%12%
Group median76%31.4%18%26%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Biogen Inc. has delivered.

$

Through the cycle, Biogen Inc. earns about $2.9B on its 29.2% median owner-earnings margin. This year’s 20.7% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.

Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+1%/yr
Owner-earnings growth · ’16→’25−5%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $2.4B on 148M shares outstanding, per the 10-Q cover, as of 2026-04-27; net cash $65M. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Biogen Inc. (BIIB), the owner's record," https://ownerscorecard.com/c/BIIB, data as of 2026-07-09.

Manual order: ← BHRB its page in the Manual BILL →

Industry order: ← BEAM the Biotechnology chapter BNTX →